The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
M

Systemic Treatment for Advanced HCC: Can Sorafenib Improve PFS/ORR vs. Lenvatinib in Unresectable Disease? Is There OS Benefit With Regorafenib After Sorafenib?

By The Asian Oncology Society 1st Virtual International Conference FEATURING Minsig Choi
By The Asian Oncology Society 1st Virtual International Conference FEATURING Minsig Choi
332 views
February 22, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

09:52
Deciphera

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Feat. K. Polson
Gastrointestinal
18:54

Genomic Era of CRC Surgery: Total Mesorectal Excision, CME & CVL, Ta…

The Asian Oncology Society 1st Virtual International Conference

S. Lee

89 views
50:29

Biomarker Driven and Targeted Therapies in CRC: dMMR/MSI-H, HER2 Ove…

The Asian Oncology Society 1st Virtual International Conference

H. Lenz

360 views
16:45

Systemic Treatment for Advanced HCC: Can Sorafenib Improve PFS/ORR v…

The Asian Oncology Society 1st Virtual International Conference

M. Choi

332 views
14:13

IO in Advanced HCC: Can We Achieve Better ORR With 1L Nivo+Ipi? Does…

The Asian Oncology Society 1st Virtual International Conference

M. Choi

150 views
14:19

NGS for Pancreatobiliary Cancer: Maintenance Olaparib Data in Germli…

The Asian Oncology Society 1st Virtual International Conference

M. Choi

354 views
22:56

Managing Gastric Cancer: Can Genetic Analysis and NGS Help? Should W…

The Asian Oncology Society 1st Virtual International Conference

K. Yoshida

32 views
11:02

Present & Future of Targeted Therapy for Advanced CRC: IO for dMMR/M…

The Asian Oncology Society 1st Virtual International Conference

J. Li

211 views